Omay EECP Machine
Product Principle:
EECP machine is triggered by patient's heart beat.While doing EECP treatment,Patient will be
lying on the bed and cuffs wrapped around lower limbs,The EECP bed includes a pressure source
that inflates and deflates these cuffs.The pressure moves the blood from lower limbs toward the
heart.Each wave of pressure is timed with your heart beat via ECG signal.So that the increased
blood flow is delivered to heart at the precise moment when heart relaxing.When heart pumps
again,the pressure in cuffs is withdrawn immediately,so that blood pumped more easily from the
heart.
EECP just like an external heart,two hearts work for patient.Greatly increases blood perfusion and
blood supply to vital organs.
Product Performance:
EECP is a non-invasive device for the treatment of cardiovascular and cerebrovascular ischemic
diseases.EECP synchronously controls the cuffs to pressurize the calf,thigh and buttocks orderly
through ECG signal,so that blood is concentrated in the upper body during diastole,thereby
promoting the blood perfusion of important organs and improving the symptoms of coronary
artery insufficiency.
Scope of application:
It is used to improve the symptoms of insufficient coronary artery blood supply
Mechanism of action: EECP treatment can increase the shear stress of blood flow on vascular wall,improve vascular endothelial function and inhibit coronary spasm.Increase myocardial perfusion,reduce left ventricular energy consumption,improve peripheral vascular function and improve exercise tolerance.。
Clinical benefit EECP can significantly improve coronary blood flow and treat stable angina.Combined with drug therapy,it can promote the formation of coronary collateral vessels,improve coronary blood flow reserve and exercise tolerance in patients with refractory angina.Improved angina sysmptoms and quality of life,and most patients continued to benefit during clinical follow-up of six months,one year,two years or even three years after treatment;Improve cardiac function in patients with New York Heart Association(NYHA) Grade II to III ischemic cardiomyopathy;Early treatment with EECP can prevent target vessel restenosis after coronary revascularization.In patients with angina pectoris.EECP treatment can reduce the number of chest pain attacks and the amount of nitroglycerin.EECP can improve the quality of life of patients who cannot tolerate stent surgery.Patients with non-obstructive coronary ischemic disease also benefit from EECP treatment;In addition,EECP treatment can also reduce patient’s anxiety and depression.
|
Brand
|
Omay
|
|
Trigger ratio
|
1:1 and 1:2,1:2 is for the patients whose heart rate is high
|
|
AF mode
|
with AF mode for the atrial fibrillation patients
|
|
Pressure range
|
50~350mmHg
|
|
Certificate
|
CE,SFDA,US FDA 510K
|
Contact Details:
Attn:Jane Liao
Whatsapp/Phone/Wechat:+86-18520667125
Email:sales@eecpcn.com
